Differential Responses of Skin Cancer-Chemopreventive Agents Silibinin, Quercetin, and Epigallocatechin 3-Gallate on Mitogenic Signaling and Cell Cycle Regulators in Human Epidermoid Carcinoma A431 Cells
- 1 March 2001
- journal article
- research article
- Published by Taylor & Francis in Nutrition and Cancer
- Vol. 39 (2) , 292-299
- https://doi.org/10.1207/s15327914nc392_20
Abstract
Silibinin, quercetin, and epigallocatechin 3-gallate (EGCG) have been shown to be skin cancer-preventive agents, albeit by several different mechanisms. Here, we assessed whether these agents show their cancer-preventive potential by a differential effect on mitogenic signaling molecules and cell cycle regulators. Treatment of human epidermoid carcinoma A431 cells with these agents inhibited the activation of the epidermal growth factor receptor and the downstream adapter protein Shc, but only silibinin showed a marked inhibition of mitogen-activated protein kinase-extracellular signal-regulated kinase-1 and -2 activation. In terms of cell cycle regulators, silibinin treatment showed an induction of Cip1/p21 and Kip1/p27 together with a significant decrease in cyclin-dependent kinase (CDK)-4, CDK2, and cyclin D1. Quercetin treatment, however, resulted in a moderate increase in Cip1/p21 with no change in Kip1/p27 and a decrease in CDK4 and cyclin D1. EGCG treatment also led to an induction of Cip1/p21 but no change in Kip1/27, CDK2, and cyclin D1 and a decrease in CDK4 only at low doses. Treatment of cells with these agents resulted in a strong dose- and time-dependent cell growth inhibition. A high dose of silibinin and low and high doses of quercetin and EGCG also led to cell death by apoptosis, suggesting that a lack of their inhibitory effect on mitogen-activated protein kinase-extracellular signal-regulated kinase-1 and -2 activation possibly "turns on" an apoptotic cell death response associated with their cancer-preventive and anticarcinogenic effects. Together, these results suggest that silibinin, quercetin, and EGCG exert their cancer-preventive effects by differential responses on mitogenic signaling and cell cycle regulators.Keywords
This publication has 32 references indexed in Scilit:
- Detrimental effect of cancer preventive phytochemicals silymarin, genistein and epigallocatechin 3‐gallate on epigenetic events in human prostate carcinoma DU145 cellsThe Prostate, 2001
- Significant inhibition by the flavonoid antioxidant silymarin against 12‐O‐tetradecanoylphorbol 13‐acetate–caused modulation of antioxidant and inflammatory enzymes, and cyclooxygenase 2 and interleukin‐1α expression in SENCAR mouse epidermis: Implications in the prevention of stage I tumor promotionMolecular Carcinogenesis, 1999
- Modulation of Mitogen-Activated Protein Kinase Activation and Cell Cycle Regulators by the Potent Skin Cancer Preventive Agent SilymarinBiochemical and Biophysical Research Communications, 1999
- Skin Cancer Chemopreventive Effects of a Flavonoid Antioxidant Silymarin Are Mediated via Impairment of Receptor Tyrosine Kinase Signaling and Perturbation in Cell Cycle ProgressionBiochemical and Biophysical Research Communications, 1998
- Green Tea Constituent Epigallocatechin-3-Gallate and Induction of Apoptosis and Cell Cycle Arrest in Human Carcinoma CellsJNCI Journal of the National Cancer Institute, 1997
- Novel Cancer Chemopreventive Effects of a Flavonoid Antioxidant Silymarin: Inhibition of mRNA Expression of an Endogenous Tumor Promoter TNFαBiochemical and Biophysical Research Communications, 1997
- Signal Transduction Mechanisms in PhotocarcinogenesisPhotochemistry and Photobiology, 1996
- Prevention of photocarcinogenesis by topical administration of pure epigallocatechin gallate isolated from green teaNutrition and Cancer, 1996
- Tyrosine Kinase Inhibition: An Approach to Drug DevelopmentScience, 1995
- Cyclins and cancer II: Cyclin D and CDK inhibitors come of ageCell, 1994